MedTrace Logo

Cardiovascular Effects of Adderall in Healthy Adults.

NCT02979327 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2025-01-14

Study results available
· View outcomes & findings →

Summary

This study is designed to investigate the cardiovascular response (blood pressure, heart rate, electrocardiographic response and blood vessel reactivity response) to taking Adderall in healthy adults.

Conditions

  • Hemodynamics
  • Cardiovascular System

Interventions

DRUG

Adderall capsule

25 mg orally one time

DRUG

Placebo capsule

Looks exactly like the study drug, but it contains no active ingredient. Taken one time.

Sponsors & Collaborators

Principal Investigators

  • Anna Svatikova, MD · Mayo Clinic

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-06-01
Primary Completion
2021-07-23
Completion
2021-07-23
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02979327 on ClinicalTrials.gov